Changes to the website
Sponsored By
Cleveland Clinic Brain Tumor and Neuro-Oncology Center
Please Click On The Above Banner For More Details
Braintumor Website

This is a list of chages to the website.

You can Subscribe to our RSS FEED: Subscribe to our RSS feed, which delivers brain tumor news and additions to the website via RSS.
(Click HERE for details on RSS.)

Displaying items 26 to 50 of about 4796

Previous 25           Next 25
Website Changes
03/05/2019 Brain tumor advocacy alert - we need you to watch this video Wednesday Morning 3/6/19 at 9am Eastern Time!
03/02/2019 Parkinson’s and cancer hope from implant drilled into skull to deliver drugs with pinpoint precision
03/02/2019 The sneaky way estrogen drives brain metastasis in non-estrogen-dependent breast cancers
02/27/2019 Medicare meeting about Optune! Tune in this Wednesday March 6, 2019
02/23/2019 Improved survival of glioblastoma patients treated at academic and high-volume facilities: a hospital-based study from the National Cancer Database.
02/22/2019 Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial
02/22/2019 Tocagen is looking for patients with high grade glioma (glioblastoma or anaplastic astrocytoma) and caregivers to participate in an advisory board event in San Diego from March 20-21st.
02/21/2019 Major Advocacy Issure: Optune
02/21/2019 Malaria drug successfully treats 26-year-old brain cancer patient
02/17/2019 why some brain tumors respond to immunotherapy
02/17/2019 Confirmation of high therapeutic effect in doctor-led clinical trials of viral therapy for brain tumor - Application for approval for the manufacture and marketing of the first cancer treatment viral drug in Japan -
02/15/2019 Statins, NSAIDS Have No Apparent Survival Benefit for Grade IV Glioma
02/14/2019 Contractor Advisory Committee (CAC) Meeting Information - Tumor Treatment Field Therapy (L34823)
02/14/2019 University of Minnesota First in U.S. to Offer New Targeted Therapy for Recurrent Brain Tumors
02/13/2019 Aspirin inhibits cancer stem cells properties and growth of glioblastoma multiforme through Rb1 pathway modulation
02/13/2019 Progesterone is more effective than dexamethasone in prolonging overall survival and preserving neurologic functions in experimental animals with orthotopic glioblastoma allografts.
02/13/2019 Suppression of HMGB1 Released in the Glioblastoma Tumor Microenvironment Reduces Tumoral Edema.
02/13/2019 Race influences survival in glioblastoma patients with KPS =?80 and associates with genetic markers of retinoic acid metabolism.
02/13/2019 Oncotelic Reports that It`s Proprietary In-Situ Cancer Vaccine Improved Survival over Standard Chemotherapy in Patients with Recurrent Metastatic Pancreas Cancer and Recurrent High Grade Glioma
02/12/2019 Treatment of Glioblastoma (GBM) with the Addition of Tumor-Treating Fields (TTF): A Review
02/12/2019 Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma.
02/11/2019 Ziopharm Oncology Completes Enrollment of Controlled IL-12 Monotherapy Expansion Substudy in Phase 1 Brain Cancer Trial
02/10/2019 Medicenna Presents Promising Clinical Data from Phase 2b Recurrent Glioblastoma Trial of MDNA55
02/06/2019 Brain Tumor `Pied Piper` Device Gains Breakthrough Status
02/05/2019 Moleculin Biotech (MBRX) Announces FDA Orphan Drug Designation for its Brain Tumor Drug



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740